Bruck Kifle

Array ( [id] => 6007012 [patent_doc_number] => 20110059043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'CHEMICAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/874512 [patent_app_country] => US [patent_app_date] => 2010-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33215 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059043.pdf [firstpage_image] =>[orig_patent_app_number] => 12874512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10038179 [patent_doc_number] => 09078874 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'Composition and method for treating cognitive impairments in down syndrom subjects' [patent_app_type] => utility [patent_app_number] => 13/392044 [patent_app_country] => US [patent_app_date] => 2010-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 21595 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9691860 [patent_doc_number] => 08822453 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation' [patent_app_type] => utility [patent_app_number] => 13/388442 [patent_app_country] => US [patent_app_date] => 2010-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 172336 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626766 [patent_doc_number] => 08796447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Process for producing benzo[B][1,4]diazepine-2,4-dione compound' [patent_app_type] => utility [patent_app_number] => 13/391468 [patent_app_country] => US [patent_app_date] => 2010-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13523 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13391468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4464606 [patent_doc_number] => 07935705 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-03 [patent_title] => 'N-alkylated rifampin' [patent_app_type] => utility [patent_app_number] => 12/854937 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3925 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/935/07935705.pdf [firstpage_image] =>[orig_patent_app_number] => 12854937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8266096 [patent_doc_number] => 20120165527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => ' PROCESS FOR THE PREPARATION OF PURE PALIPERIDONE' [patent_app_type] => utility [patent_app_number] => 13/388173 [patent_app_country] => US [patent_app_date] => 2010-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1571 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196693 [patent_doc_number] => 20110028451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'Dihydrobenzoindazoles' [patent_app_type] => utility [patent_app_number] => 12/845813 [patent_app_country] => US [patent_app_date] => 2010-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21381 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028451.pdf [firstpage_image] =>[orig_patent_app_number] => 12845813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313633 [patent_doc_number] => 20120190654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'NOVEL BICYCLIC UREA COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/388952 [patent_app_country] => US [patent_app_date] => 2010-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28109 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8398440 [patent_doc_number] => 08268815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Pyrimidine compounds and use thereof' [patent_app_type] => utility [patent_app_number] => 12/842776 [patent_app_country] => US [patent_app_date] => 2010-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20741 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12842776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6136558 [patent_doc_number] => 20110009393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof' [patent_app_type] => utility [patent_app_number] => 12/838565 [patent_app_country] => US [patent_app_date] => 2010-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24374 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009393.pdf [firstpage_image] =>[orig_patent_app_number] => 12838565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153599 [patent_doc_number] => 08586505 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => '4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use' [patent_app_type] => utility [patent_app_number] => 13/378866 [patent_app_country] => US [patent_app_date] => 2010-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35459 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13378866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6446853 [patent_doc_number] => 20100279986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'HETEROCYCLIC DERIVED METALLOPROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/834283 [patent_app_country] => US [patent_app_date] => 2010-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37573 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279986.pdf [firstpage_image] =>[orig_patent_app_number] => 12834283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9677022 [patent_doc_number] => 08815932 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Induction of alpha helix conformations in proteins and peptides' [patent_app_type] => utility [patent_app_number] => 13/383266 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13004 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4456248 [patent_doc_number] => 07893052 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'CGRP receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/831802 [patent_app_country] => US [patent_app_date] => 2010-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36836 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/893/07893052.pdf [firstpage_image] =>[orig_patent_app_number] => 12831802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465689 [patent_doc_number] => 20120270857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => '5-HT3 RECEPTOR MODULATORS, METHODS OF MAKING, AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/384050 [patent_app_country] => US [patent_app_date] => 2010-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46056 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6236415 [patent_doc_number] => 20100267690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'TRICYCLIC GUANIDINE DERIVATIVES AS SODIUM-PROTON EXCHANGE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/827277 [patent_app_country] => US [patent_app_date] => 2010-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 98651 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267690.pdf [firstpage_image] =>[orig_patent_app_number] => 12827277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6339908 [patent_doc_number] => 20100247519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/794858 [patent_app_country] => US [patent_app_date] => 2010-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11922 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247519.pdf [firstpage_image] =>[orig_patent_app_number] => 12794858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8041605 [patent_doc_number] => 20120070512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'Substituted 6-(2-hydroxybenzylamino)purine Derivatives, Their Use as Medicaments and Compositions Containing These Derivatives' [patent_app_type] => utility [patent_app_number] => 13/375343 [patent_app_country] => US [patent_app_date] => 2010-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22502 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20120070512.pdf [firstpage_image] =>[orig_patent_app_number] => 13375343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6617340 [patent_doc_number] => 20100324021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => '(DIHYDRO)IMIDAZOISO[5,1-A]QUINOLINES' [patent_app_type] => utility [patent_app_number] => 12/786996 [patent_app_country] => US [patent_app_date] => 2010-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42067 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20100324021.pdf [firstpage_image] =>[orig_patent_app_number] => 12786996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177723 [patent_doc_number] => 20110178069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME' [patent_app_type] => utility [patent_app_number] => 12/786221 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 133922 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178069.pdf [firstpage_image] =>[orig_patent_app_number] => 12786221 [rel_patent_id] =>[rel_patent_doc_number] =>)